Quick Win by the Algorithm

On January 15, 2017 the I Know First algorithm had predicted a bullish forecast for ARIAD Pharmaceuticals, Inc. (ARIA)  had a signal of 56.58 and a predictability of 0.03. In accordance with the algorithm, the company reported long-position capital gains of 72.49% experiencing a quick win by the algorithm.

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. ARIAD is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.

ARIAD Pharmaceuticals, Inc., (NASDAQ:ARIA) reported a boost in its shares after the definitive agreement to be bought out by the leading Japanese company Takeda Pharmaceuticals for $24 per share or 5.2 billion.
This transaction will positively affect these two companies since both ARIAD and Takeda are interested in helping cancer patients worldwide; furthermore, this deal represents an opportunity to gain better performances, guaranteeing profitable returns to their shareholders.

Before making any trading decisions, consult the latest forecast as the algorithm constantly updates predictions daily. While the algorithm can be used for intra-day trading the predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.

Missed the latest trend? Looking for the next best market opportunity? Find out today’s stock forecast based on our advanced self-learning algorithm